Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBS versus serum tamoxifen and endoxifen concentration study
NL-OMON37023Recruiting
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tamoxifen in breast cancer, sponsored by none. Started Mar 2013; status: recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON37023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37023.